3004.90.92.58/Imodium Multi-Symptom Relief Caplets/Japan

Imodium Multi-Symptom Relief Caplets from Japan

Combination caplets containing loperamide HCl plus simethicone for diarrhea with gas and bloating relief. Despite multiple actives, primary classification under HTS 3004.90.92.58 is driven by loperamide content affecting the digestive system, put up in retail measured doses.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• List all active ingredients on commercial invoice; loperamide determines primary HTS but declare full composition

• Obtain prior notice via FDA's PNSI system for combination drug products containing loperamide

Imodium Multi-Symptom Relief Caplets from Japan — Import Duty Rate | HTS 3004.90.92.58